Short-term vagus nerve stimulation reduces myocardial apoptosis by downregulating microRNA-205 in rats with chronic heart failure

Previous studies have reported that short‑term vagus nerve stimulation (VNS) improves cardiac function in rats with chronic heart failure (CHF). The molecular mechanisms are unclear. The potential effect of microRNA (miR)‑205 in apoptosis of short‑term VNS was examined. A total of 3 weeks after inducing CHF, the rats were divided into three groups: Sham stimulation in sham operated rats, sham stimulation in CHF rats (CHF‑SS), and treated with VNS in CHF rats (CHF‑VNS). The right vagus nerve of the neck was stimulated for 72 h in CHF rats with rectangular pulses of 40 msec duration at 1 Hz and 5 V. miR‑205 was focused on, which exhibited differential expression in the miRNA microarray analysis of CHF rats, and the effects of VNS on apoptosis were examined. It was verified that the expression level of miR‑205 in the CHF‑SS group was increased, and the expression was reduced in the CHF‑VNS group. Furthermore, mimics or inhibitor of miR‑205 was transfected into H9c2 to investigate its function on apoptosis. Baculoviral IAP repeat‑containing protein 2 (Birc2) was confirmed a target of miR‑205 through a dual luciferase reporter assay and western blotting. It was demonstrated that downregulated miR‑205 decreased apoptosis in H9c2 cells. The apoptosis‑associated proteins were further detected in H9c2 cells and rat tissue. The mRNA and protein expression levels of caspase‑3 and Bcl‑2‑associated X protein were decreased in the CHF‑VNS group, the expression of Birc2 and B‑cell lymphoma 2 were increased. The results were consistent with the in vitro study in the miR‑205 inhibitor group. The present study demonstrated that short‑term VNS decreased apoptosis by downregulating miR‑205 in rats with CHF. Therefore, the results of the present study provide basic evidence for short‑term VNS in the clinical treatment of CHF.